NL-OMON19993
Completed
Not Applicable
High-Flow Nasal Cannula for severe COVID-19, a multicentre prospective cohort study
o sponsors0 sites600 target enrollmentTBD
Conditions<p>COVID-19</p>
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- <p>COVID-19</p>
- Sponsor
- o sponsors
- Enrollment
- 600
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •The population included will be hospitalized patients with confirmed COVID\-19, \= 18 years old with isolated severe hypoxic respiratory failure defined as: SpO2 \< 92% and/or BF\>30/min despite treatment with at least 6 L/min oxygen therapy on nasal cannula. These patients may be included at the pulmonary departments delivering COVID\-19 care, intensive care units or directly on the Emergency department. SARS\-CoV\-2 negative patients (nasopharyngeal PCR) will be excluded for this analysis, retrospectively.
- •Inclusion criteria
- •In order to be eligible to participate in this study, a subject must meet all of the following inclusion criteria:
- •? Age \= 18 years
- •? Admitted to the hospital
- •? Suspect of COVID\-19 or nasopharyngeal swab PCR confirmed COVID\-19
- •? SpO2 \< 92% and/ or breathing frequency \>30/min despite at least 6L O2/min on nasal cannula.
Exclusion Criteria
- •A potential subject who meets any of the following criteria will be excluded from participation in this study:
- •? Reasons for direct intubation, as per local standard of clinical care.
- •? Patient does not accept treatment with HFNC
- •? Anatomic abnormalities (recent surgery of the face, nose, or airway) that preclude an appropriate\-fitting nasal cannula
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Impact of high flow oxygen therapy on outcomes of COVID-19 patientsCTRI/2020/10/028634Rajendra Institute of Medical Sciences114
Completed
Not Applicable
HFNC and NIV for COVID-19 Complicated by Respiratory FailureRespiratory FailureNCT04452708Chinese University of Hong Kong26
Recruiting
Not Applicable
Intranasal LMWH against COVID-19COVID-19NL-OMON28133ZonMW34
Completed
Not Applicable
ong-term high-flow nasal cannula therapy in patients with stable COPD: a prospective, randomized crossover studyChronic Obstructive Pulmonary Disease (COPD)JPRN-UMIN000017639Kobe City Medical Center General Hospital Department of Respiratory Medicine30
Not yet recruiting
Not Applicable
High Flow Nasal Oxygen Therapy in COVID-19 patientsHealth Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereCTRI/2020/12/030015All India Institute of Medical Sciences Jodhpur